A study designed to investigate why lung cancer incidence has increased among younger nonsmokers over the past few decades ...
Glooko, Inc., a globally integrated digital healthcare company focused on helping healthcare systems solve the growing challenges of glycemic safety and diabetes management across care settings, today ...
Blood-pressure reduction is the only proven treatment to prevent stroke. Whether a single pill that combines three ...
Background Cancer survivors often face the risk of developing heart failure (HF) as a result of their previous cancer therapy ...
Background To investigate prevalence and risk factors of epiretinal membrane (ERM), particularly those associated with ERM ...
Dizal Pharmaceutical's Zegfrovy has taken the EGFR inhibitor class into new territory after hitting the mark in a phase 3 trial as a first-line treatment for non-small cell lung cancer (NSCLC) with ...
Background and objective Kidney transplant recipients (KTRs) face elevated cardiovascular risk, partly due to reduced ...
The Atlanta Voice has stood as a pillar of truth, empowerment, and advocacy in Metro Atlanta for six decades. As we celebrate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results